Bright Minds Biosciences Inc Cash Flow Quality Index

Latest as of December 2024: -30.12x

Bright Minds Biosciences Inc cash flow quality index. Bright Minds Biosciences Inc (DRUG) has a Cash Flow Quality Index of -30.12x as of December 2024. Operating cash flow of $-1.49 Million is below net income of $49.61K, suggesting accrual-heavy earnings not yet converted to cash. See financial flexibility index of Bright Minds Biosciences Inc to measure the company's free cash flow as a share of total liabilities.

Cash Flow Quality Index

-30.12x
Operating CF / Net Income

Operating Cash Flow

$-1.49 Million
USD

Net Income

$49.61K
USD

Data as of

Dec 2024
Most recent filing

Bright Minds Biosciences Inc Cash Flow Quality Index by Year (None–None)

Bright Minds Biosciences Inc cash flow quality index by year from None to None. Year-by-year earnings quality comparison for Bright Minds Biosciences Inc. For the full cash flow conversion analysis, see DRUG operating cash flow.

Year Quality Index Operating CF (USD) Net Income YoY Change
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.